Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Bacterial test, Bilirubin urine, Blood urine, Discomfort, Glucose urine
Clinical narrative: Symptoms like UTI; Feeling Discomfort; Pain; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Symptoms like UTI), DISCOMFORT (Feeling Discomfort) and PAIN (Pain) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced URINARY TRACT INFECTION (Symptoms like UTI), DISCOMFORT (Feeling Discomfort) and PAIN (Pain). The patient was treated with FLUCONAZOLE for Adverse event, at an unspecified dose and frequency; SULFAMETHOXAZOLE for Adverse event, at an unspecified dose and frequency; AZITHROMYCIN (AZO) for UTI, at an unspecified dose and frequency and MANNOSE, D- for Adverse event, at an unspecified dose and frequency. At the time of the report, URINARY TRACT INFECTION (Symptoms like UTI), DISCOMFORT (Feeling Discomfort) and PAIN (Pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, Bilirubin urine: negative (Negative) Standard range- Negative. On 19-May-2021, Glucose urine: negative (Negative) Standard Range- NEG mg/dl. On 19-May-2021, Nitrite urine: negative (Negative) Standard range-Negative. On 19-May-2021, Protein urine: neg mg/dl (Negative) Standard range- NEG-TRACE mg/dl. On 19-May-2021, Specific gravity urine: 1.010 (normal) Standard range- 1.005-1.030. On 19-May-2021, Urine analysis: negative (Negative) Standard range- Negative and 0.2-1.0 e.u./dl (normal) Standard range-0.2-1.0 E.U./dl. On 19-May-2021, Urine ketone body: negative (Negative) Standard range- NEG mg/dl. On 19-May-2021, White blood cell agglutination present: negative (Negative) Standard range-NEG. On 19-May-2021, pH urine: 6.0 (normal) Standard range-5.0-8.0. On 08-Jul-2021, Bacterial test: 1+(abnormal) (Positive) 1+(Abnormal). On 08-Jul-2021, Blood urine: negative (Negative) Reference range-negative. On 08-Jul-2021, Glucose urine: negative (Negative) Reference range-negative. On 08-Jul-2021, Nitrite urine: negative (Negative) Reference range-negative. On 08-Jul-2021, Protein urine: negative (Negative) Reference range-negative. On 08-Jul-2021, Specific gravity urine: 1.016 (normal) Reference range-1.005-1.030. On 08-Jul-2021, Urinary sediment: abnormal (abnormal) Abnormal. On 08-Jul-2021, Urinary sediment present: 1+ (Positive) 1+. On 08-Jul-2021, Urine analysis: abnormal (abnormal) Urine C/S. On 08-Jul-2021, Urine ketone body: negative (Negative) Reference range-negative. On 08-Jul-2021, Urine leukocyte esterase: 1+abnormal (abnormal) Reference range-negative. On 08-Jul-2021, White blood cells urine: 1+(abnormal) (Positive) 1+(Abnormal). On 08-Jul-2021, pH urine: 7.0 (normal) Reference range-5.0-8.0. On 26-Jul-2021, Blood urine: negative (Negative) Reference range-negative. On 26-Jul-2021, Glucose urine: negative (Negative) Reference range-negative Glucose, Qualitative urine. On 26-Jul-2021, Nitrite urine: negative (Negative) Reference range-negative. On 26-Jul-2021, Protein urine: negative (Negative) Reference range-negative. On 26-Jul-2021, Specific gravity urine: 1.010 (normal) Reference range-1.005-1.030. On 26-Jul-2021, Urine ketone body: negative (Negative) Reference range-negative. On 26-Jul-2021, Urine leukocyte esterase: negative (Negative) Reference range-negative. On 26-Jul-2021, pH urine: 5.5 (normal) Reference range-5.0-8.0.         No concomitant medications were reported. Patient took Uquora supplements to treat urinary tract infection.  On 19-May-2021, the patient's urine color was yellow with a clear clarity.  On 24-May-2021, the patient's urine culture showed 11,000 to 50,000 Col/mL of citrobacter koseri (diversus) infection. The patient's urine culture also indicated positive for Staphylococcus aureus, coagulase within a range of 1,000 to 10,000 Col/mL.  Cefazolin susceptibility inferred from oxacillin result.  On 08-Jul-2021, Trichomonas Antigen screen test was negative. On 26-Jul-2021, Trichomonas Antigen screen test was negative.  Even though the test results did not have any serious abnormalities but due to the slight presence of bacteria, the physician prescribed Flucanazole and sulfamethoxazole to the patient. The treatment did not make any difference for the patient's health. The patient had the practice of drinking about 2.5 litres of water everyday.   Most recent FOLLOW-UP information incorporated above includes: On 16-Sep-2021: Updated vaccine facility information, Updated Patient demographics- Height, Weight, Pregnancy status, Race, Ethnicity. Contains-Suspect drug batch no, The adverse event start date for UTI like symptoms was updated.